Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.43 |
| ▸ | RAB9A | P51151 | 7/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.43 |
| ▸ | RELA | Q04206 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 9/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21313409 | 0.86 | SNCA (0.55) | SNCASMN1; SMN2RAB9ANFKB1NFKB2 | |
| SCHEMBL21319434 | 0.85 | RAB9A (0.57) | SMN1; SMN2RAB9ANFKB1NFKB2RELA | |
| SCHEMBL19106702 | 0.84 | RAB9A (0.51) | SNCASMN1; SMN2RAB9ANFKB1NFKB2 | |
| SCHEMBL30837503 | 0.84 | RAB9A (0.51) | SNCASMN1; SMN2RAB9ANFKB1NFKB2 | |
| SCHEMBL2496185 | 0.81 | RAB9A (0.53) | SNCASMN1; SMN2RAB9ANFKB1NFKB2 | |
| SCHEMBL20894815 | 0.81 | RAB9A (0.52) | SMN1; SMN2RAB9ANFKB1NFKB2RELA | |
| SCHEMBL20894612 | 0.80 | RAB9A (0.51) | SMN1; SMN2RAB9ANFKB1NFKB2RELA | |
| SCHEMBL22466378 | 0.79 | RAB9A (0.66) | SMN1; SMN2RAB9ANFKB1NFKB2RELA | |
| SCHEMBL1448847 | 0.75 | SNCA (0.66) | SNCASMN1; SMN2RAB9ALMNATP53 | |
| SCHEMBL24332039 | 0.73 | RAB9A (0.64) | SMN1; SMN2RAB9ANFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3470398-B1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2022-05-04 | — | — | EP | disclosed |
| EP-3470398-B1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2022-05-04 | — | — | EP | disclosed |
| US-20200317704-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-10-08 | — | — | US | disclosed |
| US-20200317704-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-10-08 | — | — | US | disclosed |
| WO-2019072932-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2019-04-18 | — | — | WO | disclosed |
| EP-3470398-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | Novaled GmbH (DE) | 2019-04-17 | — | — | EP | disclosed |
| EP-3470398-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | Novaled GmbH (DE) | 2019-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317704-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | SELE, EPCAM, OR51E2 | SNCA 621/4885SMN1; SMN2 3935/4885RAB9A 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.